Gabapentin Dementia Lawsuit

Were you or a loved one diagnosed with Dementia or Cognitive Decline after long-term gabapentin use? The lawyers at Johnson//Becker, PLLC, are currently investigating cases on behalf of individuals diagnosed with cognitive decline and dementia after the long-term prescribed use of gabapentin or pregabalin. Learn more below.

Studies Show Growing Concerns Over an Association Between Long-Term Gabapentin Usage and Dementia

Gabapentin was introduced to the United States market in February of 1994 under the name brand-name Neurontin. Initially, its designated purpose was to treat epilepsy and curb seizures. However, since its launch, it has been used to treat a wide array of conditions, including nerve pain, restless leg syndrome, and insomnia. Similarly, pregabalin, sold under the brand name Lyrica, is a drug in the same family of compounds. Many of the conditions for which they are prescribed are off-label, which means doctors often prescribe them for conditions other than those for which the FDA approved the uses of the drugs. Patients using gabapentin or pregabalin for conditions such as back pain, anxiety, mental health conditions, general nerve pain, and migraines may be receiving the medication when the risks may not have been fully disclosed to patients or prescribers.

Recent and emerging research studies may have found an association between long-term gabapentin use, and the development of dementia or cognitive decline in patients. This potential association raises notable inquiries about the interworking mechanisms of the drug and how it may impact brain health. According to postdoctoral researcher, GYeon Oh, “Gabapentin binds to parts of calcium channels that help control how nerve cells send signals. Scientists have several theories about how this might change brain function, but the exact way gabapentin works in the brain is still not fully understood.”

  • A study published to Regional Anesthesia & Pain Medicine found that individuals who received six or more prescriptions of gabapentin saw an increased risk of developing mild cognitive impairment at 85%, and dementia at 29%. According to an article shared to the BMJ group, “these risks were more than twice as high in those normally considered too young to develop either condition—18-64 year olds…”
  • Psychiatric News shared a report in a recent journal publication that “Adults between 35 and 49 in the gabapentin group had more than twice the risk of dementia and more than three times the risk of mild cognitive impairment than their counterparts in the non-gabapentin group.”
  • A study that was published to The National Library of Medicine observed in their research that there was “an association between gabapentin use and dementia risk.” And when prescribing gabapentin, “cognitive impairment and dementia should be considered, especially in long-term treatment, patients with higher [cumulative defined daily doses], and younger patients.”
  • Findings uncovered by a group of researchers from the University of Kentucky concluded that their “results provide evidence that gabapentin was associated with increased odds of global cognitive decline [and] functional status decline … in the 2 years following gabapentin initiation.”

Understanding the Gabapentin Lawsuits

The gabapentin lawsuits allege several claims, including that manufacturers knew or should have known about potential negative cognitive implications, that reports of neurocognitive issues were not thoroughly investigated, and that the manufacturers may have failed to properly warn patients and healthcare providers of the risks that could be associated with long term use of the drug, amongst other concerns.

What is Gabapentin?

Gabapentin, sold under the brand name ‘Neurontin’, is a prescription medication whose primary purpose is to treat certain types of seizures in patients, and is prescribed by healthcare providers to individuals suffering with nerve pain. The drug can reduce the ‘excitability’ of nerve cells in the brain, which play a role in the transmission of pain signals. Gabapentin may have been prescribed to patients with diagnoses such as fibromyalgia, restless leg syndrome, diabetic neuropathy, and insomnia. Pregabalin, sold under the brand name Lyrica, may have also been linked to an increased risk of dementia in separate research.

What is Dementia?

Dementia is an umbrella term that describes a collection of symptoms. Diseases that are grouped under the title of “dementia” are caused by abnormal changes within the brain. Dementia symptoms may lead to an overall decline in cognitive abilities that begin to impair daily life and activities, including, time disorientation, personal care, memory loss, language skills, and mood and personality shifts.

What is Cognitive Decline?

Cognitive decline is the gradual loss of mental ability that includes but is not limited to learning, attention span, and remembering.

Mild cognitive decline (MCI) can present itself as forgetting important events or recent conversations, struggling to plan for the future, limited attention span, or the frequent misplacement of items.

Gabapentin Harms We are Investigating

Gabapentin and pregabalin have been found to potentially contribute to the following harms:

  • Ongoing and permanent cognitive decline after extended prescribed use of gabapentin or pregabalin under the age of 65
  • Early-onset dementia diagnoses after extended prescribed use of gabapentin or pregabalin

Do I Qualify to Participate in a Gabapentin Lawsuit?

We are investigating claims for individuals who have suffered from the following harms after receiving six or more prescriptions for gabapentin or pregabalin:

  • Medically diagnosed cognitive decline under age 65
  • A diagnosis of early-onset dementia
  • Were prescribed gabapentin for an off-label use – a medical issue other than seizures or shingles-related nerve pain (PHN)
  • No prior history of a traumatic brain injury or schizophrenia, or a family history of early-onset dementia or Alzheimer’s Disease

Why Choose Johnson//Becker for Your Gabapentin Lawsuit?

Johnson//Becker is dedicated to serving you or your family with care, compassion, and commitment. Our lawyers have significant legal qualifications and nearly three decades of experience to best represent your interests in matters of injury due to companies putting profits over safety.

Learn More: Why Choose Us

Questions About a Gabepentin Lawsuit? Contact a Johnson//Becker Lawyer for a Free Case Review.

If you or a loved one were injured or adversely affected by the harms associated with gabapentin, you may want to speak with the lawyers at Johnson//Becker. We are currently accepting gabapentin lawsuits nationwide, and you may be entitled to financial compensation.

We offer a Free Case Evaluation. Please contact us using the form below or by calling us at (800) 279-6386.

We would be honored to speak with you and respond promptly to every inquiry we receive.

Free Case Evaluation

Verified 100% Secure Site To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (800) 279-6386.

"*" indicates required fields

SMS Message Consent